Using the immunohistochemical detection of a tissue microarray of 620 CRC samples, Fang and colleagues showed that the positivity of TROP2 correlated with liver metastases, tumor recurrence, and poor prognoses [92]. This evidence concerns the gene TACSTD2 and colorectal carcinoma.